Mesenchymal Stem Cells Show Potential to Treat NTM Lung Infections

Mesenchymal Stem Cells Show Potential to Treat NTM Lung Infections

293985

Mesenchymal Stem Cells Show Potential to Treat NTM Lung Infections

Treatment with human mesenchymal stem cells (MSCs) effectively lessened hard-to-treat non-tuberculous mycobacteria (NTM) lung infection, and its associated weight loss, in a new mouse model susceptible to these infections, an early study reported. “The potential to use human mesenchymal stem cells to treat difficult lung infections is promising,” Anthony Atala, MD, the director of the Wake Forest Institute for Regenerative Medicine and the editor-in-chief of the journal Stem Cells Translational Medicine, where the study was published,…

You must be logged in to read/download the full post.